Latest Breaking News On - வால்டர் நாணல் இராணுவம் ஆராய்ச்சி நிறுவனம் - Page 1 : comparemela.com
Woran forschen US-Biolabore in der Ukraine?
linkezeitung.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from linkezeitung.de Daily Mail and Mail on Sunday newspapers.
After SinoVac COVID-19 Vaccination, Healthy Hong Kong Man Suffers Facial Paralysis
theepochtimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theepochtimes.com Daily Mail and Mail on Sunday newspapers.
Hong Kong Public Concerned About Sinovac Vaccine Safety
The Hong Kong government began vaccinating the public with the Chinese domestically-manufactured Sinovac vaccine for free on Feb. 26, and less than three weeks later there have been seven deaths.
As of March 15, a cumulative total of 166,000 Hong Kong people had received the China-made Sinovac vaccine, also known as the “CoronaVac vaccine.”
China, which has been giving vaccines produced domestically since last year and at a much larger scale than Hong Kong, has so far released little data on adverse reactions, raising questions about a lack of transparency and the safety of the Chinese vaccines.
By Michael Wilner and Tara Copp
McClatchy Washington Bureau/TNS
WASHINGTON - Scientists at the Walter Reed Army Research Institute have promising new data indicating their vaccine will work against significant mutations of COVID-19, as well as entirely different coronaviruses, an achievement that other vaccines so far have not accomplished.
The data has yet to be peer reviewed. But the Army lab is hopeful that a pan-coronavirus vaccine is achievable after testing the drug on SARS, a coronavirus that emerged in 2003 with significant biological differences from the current pandemic disease known as SARS-CoV-2.
Tests of the vaccine against both SARS as well as emerging variants of COVID-19 have shown “very good responses,” said Dr. Kayvon Modjarrad, director of Walter Reed’s Emerging Infectious Diseases Branch.
Army’s COVID-19 vaccine may hold key to beating coronavirus mutations By Michael Wilner and Tara Copp, McClatchy Washington Bureau
Published: January 17, 2021, 2:25pm
Share:
WASHINGTON Scientists at the Walter Reed Army Research Institute have promising new data indicating their vaccine will work against significant mutations of COVID-19, as well as entirely different coronaviruses, an achievement that other vaccines so far have not accomplished.
The data has yet to be peer reviewed. But the Army lab is hopeful that a pan-coronavirus vaccine is achievable after testing the drug on SARS, a coronavirus that emerged in 2003 with significant biological differences from the current pandemic disease known as SARS-CoV-2.
vimarsana © 2020. All Rights Reserved.